B.I. Chemicals

Boehringer Ingelheim Chemicals, historically known as B.I. Chemicals, is the primary chemical manufacturing subsidiary of the global pharmaceutical company Boehringer Ingelheim. Based in Petersburg, Virginia, the company specializes in the development and large-scale production of active pharmaceutical ingredients (APIs) and advanced intermediates. It serves as a critical manufacturing hub within the Boehringer Ingelheim network and also operates as a contract development and manufacturing organization (CDMO) for external pharmaceutical partners. The facility is highly regarded for its expertise in complex small molecule synthesis and its adherence to stringent global Good Manufacturing Practice (GMP) standards. Its production output supports a wide range of therapeutic areas, including metabolic, cardiovascular, and respiratory health.